Cell Culture Media Market Report 2025

The cell culture media market size has grown rapidly in recent years. It will grow from $5.46 billion in 2024 to $6.13 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to growing research and development (R&D) activities, rising prevalence of chronic diseases, expansion of the biopharmaceutical industry, supportive government initiatives and funding, and growing demand for regenerative medicine and stem cell therapies.

The cell culture media market size is expected to see rapid growth in the next few years. It will grow to $9.54 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to an increasing focus on personalized medicine, a growing pipeline of biopharmaceutical products, expansion of stem cell research, increasing adoption of organ-on-a-chip technology for drug testing and toxicity screening, growing healthcare infrastructure, rising investments in life sciences research, and expanding biopharmaceutical manufacturing capabilities. Major trends in the forecast period include technological advancements in biotechnology, the emergence of cell and gene therapies, the adoption of organ-on-a-chip technology for drug testing and toxicity screening, the adoption of animal-free and chemically-defined cell culture media formulations, integration of advanced cell culture systems, microfluidics, and bioreactor technologies.

The forecast of 11.7% growth over the next five years reflects a modest reduction of 1.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. vaccine production by inflating prices of serum-free cell culture media manufactured in Denmark and Belgium, resulting in constrained manufacturing capacity and higher pandemic preparedness costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The expansion of pharmaceutical drug manufacturing is poised to drive growth in the cell culture media market. This surge is fueled by the rising prevalence of chronic and infectious diseases, along with an aging population, necessitating increased medication demand. Cell culture media play a pivotal role in providing the necessary nutrients and environment for optimal cell growth, crucial in producing therapeutic proteins or molecules. For example, data from June 2023 indicates that bio-pharmaceutical production in Europe saw a 4.95% increase from the previous year, totaling $384.2 billion (€340,000 million) in 2022 according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), highlighting the market's momentum.

Key players in the competitive landscape of the cell culture media market, are prioritizing the development of innovative formulations. Sin July 2023, Lonza Group Ltd., a Switzerland-based healthcare company, launched TheraPRO CHO Media System, an innovative cell culture platform designed to enhance productivity and quality in therapeutic protein manufacture. This cutting-edge platform streamlines therapeutic monoclonal antibody production with its chemically defined, animal-component-free composition, promising improved scalability and productivity in biopharmaceutical manufacturing.

In November 2022, ANGUS Chemical Company bolstered its position in the bioprocessing sector through the acquisition of Expression Systems LLC. This strategic move enhances ANGUS' capability to provide high-quality ingredients and services across all bioprocessing stages, from early development to full-scale commercial production. Expression Systems LLC, a US-based manufacturer of cell culture media and related products, adds value to ANGUS' offerings, strengthening its foothold in the market.

Major companies operating in the cell culture media market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Corning Incorporated, Lonza Group AG, Sartorius AG, CYTIVA Lifesciences, Bio-Rad Laboratories Inc., STEMCELL Technologies Inc., Miltenyi Biotec, Takara Bio, MP Biomedicals, FUJIFILM Irvine Scientific Inc., Promocell Inc., InSphero AG, PeproTech Inc., HiMedia Laboratories Pvt. Ltd., Elabscience Biotechnology Inc., Capricorn Scientific GmbH, CAISSON Laboratories Inc., Cell Biologics Inc., Nucleus Biologics LLC.

North America was the largest region in the cell culture media market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell culture media market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell culture media market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell culture media market consists of sales of co-culture media, conditioned media, and serum substitute media. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment - many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The cell culture media market research report is one of a series of new reports that provides cell culture media market statistics, including cell culture media industry global market size, regional shares, competitors with a cell culture media market share, detailed cell culture media market segments, market trends and opportunities, and any further data you may need to thrive in the cell culture media industry. This cell culture media market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cell culture media are nutrient-rich solutions crafted to nurture the growth, sustenance, and multiplication of cells outside their natural habitat. These solutions typically comprise a meticulously balanced blend of amino acids, vitamins, minerals, sugars, and growth factors customized to meet the specific needs of different cell types. The composition of the media can vary significantly based on the unique requirements of the cells and the objectives of the experiment or culture process.

The several types in cell culture media are liquid media, semi-solid media, and solid media. Liquid media are fluid-based solutions employed in various manufacturing, research, or operational activities. The different products within cell culture media include serum-free media, classical media, stem cell culture media, specialty media, chemically defined media, and others. These are utilized across diverse applications such as biopharmaceutical production, diagnostics, drug screening and development, tissue engineering, and regenerative medicine. Cell culture media find application among various end-users, including the biotechnology and pharmaceutical industries, academic institutes, research laboratories, and other relevant entities.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.